Diltiazem Hydrochloride Tablet
Product Images NDC 72578-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 72578-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viona Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (D8065fba 91ec 4dc5 86a5 869a70100565 01)

FDA Label Image

30 mg 100s Label (D8065fba 91ec 4dc5 86a5 869a70100565 02)

30 mg 100s Label (D8065fba 91ec 4dc5 86a5 869a70100565 02)
This is a description of a medication: Diltiazem Hydrochloride Tablets, USP. The tablets are to be swallowed whole, crushed, or chewed. It is advised not to spit the tablets. Each film-coated tablet contains Diltiazem Hydrochloride USP 30mg. The usual dosage can be found in the package insert. It is important to keep the medication in a tight container as defined by the USP, and it is child-resistant. The package should be kept out of the reach of children. The medication should be stored at 25°C (77°F), with excursions permitted between 15° to 30°C (59° to 86°F) to avoid excessive humidity. The medication is manufactured by Zydus Lifesciences Ltd. in India and distributed by Viona Pharmaceuticals in Cranford, NJ.*
FDA Label Image

60 mg 100s (D8065fba 91ec 4dc5 86a5 869a70100565 03)

60 mg 100s (D8065fba 91ec 4dc5 86a5 869a70100565 03)
This is information regarding Diltiazem Hydrochloride Tablets, USP 60 mg. Instructions state that the tablets can be swallowed whole, crushed, or chewed. The usual dosage information can be found in the package insert. It is recommended to store the tablets in a tight, light-resistant container at temperatures between 15-30°C. The tablets are child-resistant, and it is advised to keep them out of reach of children.*
FDA Label Image

90 mg 100s (D8065fba 91ec 4dc5 86a5 869a70100565 04)

90 mg 100s (D8065fba 91ec 4dc5 86a5 869a70100565 04)
This text includes information about a medication named Diltiazem Ditezem in tablet form, with each tablet containing 80mg of Diltiazem Hydrochloride. The tablets are described as being resistant to breaking, containing 100 tablets per package. The packaging is child-resistant, and it advises to keep all medicines out of reach of children. The medication should be stored at temperatures around 25°C, and excursions are permitted within certain limits. The manufacturing company is Zydus Lifesciences Ltd., and the distribution is handled by Viona Pharmaceuticals in New Jersey, USA. The package is labeled for prescription use only.*
FDA Label Image

120 mg 100s (D8065fba 91ec 4dc5 86a5 869a70100565 05)

120 mg 100s (D8065fba 91ec 4dc5 86a5 869a70100565 05)
This is a description of Diltiazem Hydrochloride tablets, USP. The tablets can be swallowed whole, crushed, or chewed, and each coated tablet contains Diltiazem Hydrochloride, USP. The usual dosage information can be found in the package insert. It is recommended to store the tablets at 25°C (77°F) with excursions allowed between 15-30°C (59-66°F), avoiding excessive humidity. The tablets come in a child-resistant container and must be kept out of reach of children. Manufactured by Zydus Lifesciences Ltd. and distributed by Viona Pharmaceuticals Inc., Cranford, NJ 07016.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.